Skip to main content
OpenTrials

Clinical trial condition

Recurrent Lung Non-Small Cell Carcinoma

Explore clinical trials studying Recurrent Lung Non-Small Cell Carcinoma. Study availability and eligibility vary by location and protocol.

46 public trials 11 recruiting studies
Refine in advanced search Browse all conditions

Recurrent Lung Non-Small Cell Carcinoma trial results

Active, Not Recruiting

Atezolizumab and Cobimetinib in Treating Patients With Metastatic, Recurrent, or Refractory Non-small Cell Lung Cancer

NCT03600701

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View all 18 locations
View Trial Details
Active, Not Recruiting

Testing the Effects of MK-3475 (Pembrolizumab) With or Without the Usual Chemotherapy Treatment for Patients 70 Years of Age and Older With Advanced Non-small Cell Lung Cancer

NCT04533451

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Bronchial Neoplasms, +19 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
View all 505 locations
View Trial Details

Related conditions